Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virusinfected Thais from the 2NN Cohort Study

Journal of NeuroVirology

Volumn 16, Issue 1, 2010, Pages 76-82

  Pumpradit, Wadchara ^a   Ananworanich, Jintanat ^a,b   Lolak, Sermsak ^c   Shikuma, Cecilia ^d   Paul, Robert ^e   Siangphoe, Umaporn ^b   Chaoniti, Nithima ^a   Kaew On, Peeraporn ^a   Paris, Robert ^f   Ruxrungtham, Kiat ^a   Valcour, Victor ^d,g  

^a THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^b South East Asia Research Collaboration with Hawaii ^*  (Thailand)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF HAWAII   (United States)

^e UNIVERSITY OF MISSOURI ST LOUIS   (United States)

^f ARMED FORCES RESEARCH INSTITUTE OF MEDICAL SCIENCES   (Thailand)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cognition; Dementia; HAART; HIV

Indexed keywords

ADULT; ANXIETY; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DEPRESSION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; THAILAND;

ADULT; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANXIETY; COGNITION DISORDERS; COHORT STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEPRESSION; FEMALE; HIV; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUESTIONNAIRES; THAILAND;

HUMAN IMMUNODEFICIENCY VIRUS; THAIS;

EID: 77649288748     PISSN: 13550284     EISSN: None     Source Type: Journal    
DOI: 10.3109/13550280903493914     Document Type: Article

References (26)

1. Ammassari A, Antinori A, Aloisi MS, Trotta MP, Murri R, Bartoli L, Monforte AD, Wu AW, Starace F (2004). Depressive symptoms, neurocognitive impairment, and adherence to highly active antiretroviral therapy among HIV-infected persons. Psychosomatics 45: 394-402.
2. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69: 1789-1799.
3. Brechtl JR, Breitbart W, Galietta M, Krivo S, Rosenfeld B (2001). The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: impact on medical, palliative care, and quality of life outcomes. J Pain Symptom Manage 21: 41-51.
4. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26: 307-319.
5. Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, Wright E, Chua P, Judd F (2006). Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up. HIV Med 7: 112-121.
6. Gupta JD, Satishchandra P, Gopukumar K, Wilkie F, Waldrop-Valverde D, Ellis R, Ownby R, Subbakrishna DK, Desai A, Kamat A, Ravi V, Rao BS, Satish KS, Kumar M (2007). Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India. J NeuroVirol 13: 195-202.
7. Heaton R, Franklin D, Clifford D, Woods S, Mindt M, Vigil O, Taylor M, Marcotte T, Atkinson H, GrantI (2009). Abstract 154: HIV-associated neurocognitive impairment remains prevalent in the era of combination ART: The CHARTER Study. In: 16th Conference on Retroviruses and Opportunistic Infections, Montreal, CA. February 8-11, 2009.
8. Judd F, Komiti A, Chua P, Mijch A, Hoy J, Grech P, Street A, Lloyd J, Williams B (2005). Nature of depression in patients with HIV/AIDS. Aust N Z J Psychiatry 39: 826-832.
9. Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, McArthur JC, McCutchan JA, Morgello S, Simpson D, Grant I, Ellis RJ (2008). Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65: 65-70.
10. Liner KJ 2nd, Hall CD, Robertson KR (2007). Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease. J NeuroVirol 13: 291-304.
11. Lotrakul M, Sukanich P (1999). Development of the Thai Depression Inventory. J Med Assoc Thai 82: 1200-1207.
12. Lotrakul M, Sumrithe S, Saipanish R (2008). Reliability and validity of the Thai version of the PHQ-9. BMC Psychiatry 8: 46.
13. Ranga U, Shankarappa R, Siddappa NB, Ramakrishna L, Nagendran R, Mahalingam M, Mahadevan A, Jayasuryan N, Satishchandra P, Shankar SK, Prasad VR (2004). Tat protein of human immunodeficiency virus type 1 subtype C strains is a defective chemokine. J Virol 78: 2586-2590.
14. Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ (2007). The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 21: 1915-1921.
15. Roc AC, Ances BM, Chawla S, Korczykowski M, Wolf RL, Kolson DL, Detre JA, Poptani H (2007). Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy. Arch Neurol 64: 1249-1257.
16. Sacktor N, McDermott MP, Marder K, Schifitto G, Selnes OA, McArthur JC, Stern Y, Albert S, Palumbo D, Kieburtz K, De Marcaida JA, Cohen B, Epstein L (2002). HIV-associated cognitive impairment before and after the advent of combination therapy. J Neuro-Virol 8: 136-142.
17. Sacktor N, Nakasujja N, Robertson K, Clifford DB (2007). HIV-associated cognitive impairment in sub-Saharan Africa-the potential effect of clade diversity. Nat Clin Pract Neurol 3: 436-443.
18. Sacktor N, Nakasujja N, Skolasky R, Robertson K, Wong M, Musisi S, Ronald A, Katabira E (2006). Antiretroviral therapy improves cognitive impairment in HIV+ individuals in sub-Saharan Africa. Neurology 67: 311-314.
19. Sacktor N, Nakasujja N, Skolasky RL, Rezapour M, Robertson K, Musisi S, Katabira E, Ronald A, Clifford DB, Laeyendecker O, Quinn TC (2009). HIV subtype D is associated with dementia, compared with subtype A, in immunosuppressed individuals at risk of cognitive impairment in Kampala, Uganda. Clin Infect Dis 49: 780-786.
20. Shiramizu B, Gartner S, Williams A, Shikuma C, Ratto-Kim S, Watters M, Aguon J, Valcour V (2005). Circulating proviral HIV DNA and HIV-associated dementia. AIDS 19: 45-52.
21. Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P (2007). Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr 45: 174-182. (Pubitemid 46869810)
22. Tozzi V, Balestra P, Lorenzini P, Bellagamba R, Galgani S, Corpolongo A, Vlassi C, Larussa D, Zaccarelli M, Noto P, Visco-Comandini U, Giulianelli M, Ippolito G, Antinori A, Narciso P (2005). Prevalence and risk factors for human immunodeficiency virus-associated neurocogni-tive impairment, 1996 to 2002: results from an urban observational cohort. J NeuroVirol 11: 265-273.
23. Valcour VG, Shiramizu BT, Sithinamsuwan P, Nidhinandana S, Ratto-Kim S, Ananworanich J, Siangphoe U, Kim JH, de Souza M, Degruttola V, Paul RH, Shikuma CM (2009). HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study. Neurology 72: 992-998.
24. Valcour VG, Sithinamsuwan P, Nidhinandana S, Thitivichianlert S, Ratto-Kim S, Apateerapong W, Shiramizu BT, Desouza MS, Chitpatima ST, Watt G, Chuenchitra T, Robertson KR, Paul RH, McArthur JC, Kim JH, Shikuma CM (2007). Neuropsychological abnormalities in patients with dementia in CRF 01-AE HIV-1 infection. Neurology 68: 525-527.
25. van Leth F, Phanuphak P, Ruxrungtham K, Baraldi E, Miller S, Gazzard B, Cahn P, Lalloo UG, van der Westhuizen IP, Malan DR, Johnson MA, Santos BR, Mulcahy F, Wood R, Levi GC, Reboredo G, Squires K, Cassetti I, Petit D, Raffi F, Katlama C, Murphy RL, Horban A, Dam JP, Hassink E, van Leeuwen R, Robinson P, Wit FW, Lange JM (2004). Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. Lancet 363: 1253-1263.
26. Wright E, Brew B, Arayawichanont A, Robertson K, Samintharapanya K, Kongsaengdao S, Lim M, Vonthanak S, Lal L, Sarim C, Huffam S, Li P, Imran D, Lewis J, Lun WH, Kamarulzaman A, Tau G, Ali ST, Kishore K, Bain MP, Dwyer R, McCormack G, Hellard M, Cherry C, McArthur J, Wesselingh S (2008). Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region. Neurology 71: 50-56.